Impact of the experimental conditions on drug release from parenteral depot systems: From negligible to significant

International Journal of Pharmaceutics

Volumn 432, Issue 1-2, 2012, Pages 11-22

  Delplace, C ^a,b   Kreye, F ^a,b   Klose, D ^a,b   Danede F ^a   Descamps, M ^a   Siepmann, J ^a,b   Siepmann, F ^a,b  

^a UNIV LILLE   (France)

^b France   (France)

Author keywords

Controlled release; Implants; Mathematical modeling; Microparticles; Release conditions

Indexed keywords

AGAROSE; DEXAMETHASONE; IBUPROFEN; LIDOCAINE; LIPID; PHOSPHATE BUFFERED SALINE; POLYGLACTIN; PRILOCAINE; PROPRANOLOL; THEOPHYLLINE;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EXPERIMENTAL DESIGN; FLASK; FLOW RATE; LABORATORY DEVICE; MATHEMATICAL MODEL; PARENTERAL DRUG ADMINISTRATION; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TUBE; VOLUMETRY; X RAY DIFFRACTION;

DEXAMETHASONE; DRUG IMPLANTS; IBUPROFEN; INFUSIONS, PARENTERAL; KINETICS; LACTIC ACID; LIDOCAINE; LIPIDS; PARTICLE SIZE; POLYGLYCOLIC ACID; PRILOCAINE; PROPRANOLOL; THEOPHYLLINE; X-RAY DIFFRACTION;

EID: 84861621359     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.053     Document Type: Article

References (49)

1. A. Aubert-Pouessel, D.C. Bibby, M.C. Venier-Julienne, F. Hindre, and J.P. Benoit A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres Pharm. Res. 19 2002 1046 1051
2. J.P. Benoit, N. Faisant, M.C. Venier-Julienne, and P. Menei Development of microspheres for neurological disorders: from basics to clinical applications J. Control. Release 65 2000 285 296
3. A. Brunner, K. Maeder, and A. Goepferich pH and osmotic pressure inside biodegradable microspheres during erosion Pharm. Res. 16 1999 847 853
4. D.J. Burgess, A.S. Hussain, T.S. Ingallinera, and M.L. Chen Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP Pharm. Res. 19 2002 1761 1768
5. D. Burgess, D. Crommelin, A. Hussain, and M. Chen Assuring quality and performance of sustained and controlled release parenterals Eur. J. Pharm. Sci. 21 2004 679 690
6. J. Crank The Mathematics of Diffusion second ed. 1975 Clarendon Press Oxford
7. S. D'Souza, and P.P. DeLuca Development of a dialysis in vitro release method for biodegradable microspheres AAPS PharmSciTech 6 2005 323 328
8. S. Fredenberg, M. Jönsson, T. Laakso, M. Wahlgren, M. Reslow, and A. Axelsson Development of mass transport resistance in poly(lactide-co-glycolide) films and particles - a mechanistic study Int. J. Pharm. 409 2011 194 202
9. S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review Int. J. Pharm. 415 2011 34 52
10. S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson Pore formation and pore closure in poly(d,l-lactide-co-glycolide) films J. Control. Release 150 2011 142 149
11. C. Guse, S. Koennings, T. Blunk, J. Siepmann, and A. Goepferich Programmable implants - from pulsatile to controlled release Int. J. Pharm. 314 2006 161 169
12. C. Guse, S. Koennings, A. Maschke, M. Hacker, C. Becker, S. Schreiner, T. Blunk, T. Spruss, and A. Goepferich Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids Int. J. Pharm. 314 2006 153 160
13. T. Hickey, D. Kreutzer, D.J. Burgess, and F. Moussy Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices Biomaterials 23 2002 1649 1656
14. J.G. Hiremath, C.G. Rudani, R.V. Suthar, and A.J. Domb Tamoxifen citrate loaded biodegradable poly(sebacic acid-co-ricinoleic acid) microparticles, in vitro characterization J. Drug Deliv. Sci. Technol. 21 2011 417 422
15. J. Kang, and S.P. Schwendeman Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins Mol. Pharm. 4 2007 104 118
16. D. Klose, F. Siepmann, K. Elkharraz, and J. Siepmann PLGA-based drug delivery systems: importance of the type of drug and device geometry Int. J. Pharm. 354 2008 95 103
17. D. Klose, N. Azaroual, F. Siepmann, G. Vermeersch, and J. Siepmann Towards more realistic in vitro release measurement techniques for biodegradable microparticles Pharm. Res. 26 2009 691 699
18. D. Klose, F. Siepmann, J.F. Willart, M. Descamps, and J. Siepmann Drug release from PLGA-based microparticles. Effects of the microparticle: bulk fluid ratio Int. J. Pharm. 383 2010 123 131
19. S. Koennings, A. Sapin, T. Blunk, P. Menei, and A. Goepferich Towards controlled release of BDNF - manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain J. Control. Release 119 2007 163 172
20. S. Koennings, A. Berie, J. Tessmar, T. Blunk, and A. Goepferich Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices J. Control. Release 119 2007 173 181
21. J.W. Kostanski, and P.P. DeLuca A novel in vitro release technique for peptide containing biodegradable microspheres AAPS PharmSciTech 1 2000 30 40
22. J.W. Kostanski, B.A. Dani, G.A. Reynolds, C.Y. Bowers, and P.P. DeLuca Evaluation of orntide microspheres in a rat animal model and correlation to in vitro release profiles AAPS PharmSciTech 1 2000 4 16
23. F. Kreye, F. Siepmann, and J. Siepmann Drug release mechanisms of compressed lipid implants Int. J. Pharm. 404 2011 27 35
24. F. Kreye, F. Siepmann, J.F. Willart, M. Descamps, and J. Siepmann Drug release mechanisms of cast lipid implants Eur. J. Pharm. Biopharm. 78 2011 394 400
25. F. Kreye, F. Siepmann, A. Zimmer, J.F. Willart, M. Descamps, and J. Siepmann Controlled release implants based on cast lipid blends Eur. J. Pharm. Sci. 43 2011 78 83
26. F. Kreye, F. Siepmann, A. Zimmer, J.F. Willart, M. Descamps, and J. Siepmann Cast lipid implants for controlled drug delivery: importance of the tempering conditions J. Pharm. Sci. 100 2011 3471 3481
27. Kreye, F., Hamm, G., Karrout, Y., Legouffe, R., Bonnel, D., Siepmann, F., Siepmann, J. MALDI-TOF MS imaging of controlled release implants, J. Control. Release, http://dx.doi.org/10.1016/j.jconrel.2012.04.017, in press.
28. L. Li, and S.P. Schwendeman Mapping neutral microclimate pH in PLGA microspheres J. Control. Release 101 2005 163 173
29. M. Martinez, M. Rathbone, D. Burgess, and M. Huynh In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting J. Control. Release 129 2008 79 87
30. M.N. Martinez, M.J. Rathbone, D. Burgess, and M. Huynh Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products J. Control. Release 142 2010 2 7
31. P. Menei, E. Jadaud, N. Faisant, M. Boisdron-Celle, S. Michalak, D. Fournier, M. Delhaye, and J.P. Benoit Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma Cancer 100 2004 405 410
32. P. Menei, C. Montero-Menei, M.C. Venier, and J.P. Benoit Drug delivery into the brain using poly(lactide-co-glycolide) microspheres Expert Opin. Drug Deliv. 2 2005 363 376
33. S. Mohl, and G. Winter Continuous release of rh-interferon α-2a from triglyceride matrices J. Control. Release 97 2004 67 78
34. A. Rawat, E. Stippler, V.P. Shah, and D.J. Burgess Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal® Consta® Int. J. Pharm. 420 2011 198 205
35. S. Schulze, and G. Winter Lipid extrudates as novel sustained release systems for pharmaceutical proteins J. Control. Release 134 2009 177 185
36. M. Shameem, H. Lee, and P.P. DeLuca A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations AAPS PharmSci 1 1999 1 6
37. J. Shen, and D.J. Burgess Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings Int. J. Pharm. 422 2012 341 348
38. J. Siepmann, and A. Goepferich Mathematical modeling of bioerodible polymeric drug delivery systems Adv. Drug Deliv. Rev. 48 2001 229 247
39. J. Siepmann, F. Siepmann, and A.T. Florence Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms Int. J. Pharm. 314 2006 101 119
40. J. Siepmann, and F. Siepmann Mathematical modeling of drug delivery Int. J. Pharm. 364 2008 328 343
41. F. Siepmann, S. Herrmann, G. Winter, and J. Siepmann A novel mathematical model quantifying drug release from lipid implants J. Control. Release 128 2008 233 240
42. J. Siepmann, and F. Siepmann Mathematical modeling of drug release from lipid dosage forms Int. J. Pharm. 418 2011 42 53
43. Siepmann, J., Siepmann, F. Modeling of diffusion controlled drug delivery. J. Control. Release, http://dx.doi.org/10.1016/j.jconrel.2011.10.006, in press.
44. J. Vergnaud Controlled Drug Release of Oral Dosage Forms 1993 Ellis Horwood Limited Chichester
45. C.J. White, A. Tieppo, and M.E. Byrne Controlled drug release from contact lenses: a comprehensive review from 1965-present J. Drug Deliv. Sci. Technol. 21 2011 369 384
46. B.H. Woo, J.W. Kostanski, S. Gebrekidan, B.A. Dani, B.C. Thanoo, and P.P. DeLuca Preparation, characterization and in vivo evaluation of 120-day poly(d,l-lactide) leuprolide microspheres J. Control. Release 75 2001 307 315
47. B.S. Zolnik, P.E. Leary, and D.J. Burgess Elevated temperature accelerated release testing of PLGA microspheres J. Control. Release 112 2006 293 300
48. B.S. Zolnik, and D.J. Burgess Effect of acidic pH on PLGA microsphere degradation and release J. Control. Release 122 2007 338 344
49. B.S. Zolnik, and D.J. Burgess Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres J. Control. Release 127 2008 137 145